Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM. Source: Department of Pathology, The Norwegian Radium Hospital and Institute for Cancer Research, University of Oslo, Montebello. Abstract: A significant higher incidence of some cancers, especially lung cancer, has been found in women with previous HPV-related (human papillomavirus) urogenital and anal neoplasias than […]
Detection of HPV 16 and 18 DNA in the blood of patients with cervical cancer
Kay P, Allan B, Denny L, Hoffman M, Williamson AL. Source: Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa. Abstract: Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of […]
Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer.
Castle PE. SourceDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. castlep@mail.nih.gov Abstract Human papillomavirus (HPV) is the necessary but probably not sufficient cause of cervical precancer and cancer. Secondary exogenous and endogenous factors, HPV cofactors, may contribute to the probability of a cancer-associated (oncogenic) HPV infection progressing to cervical precancer and […]
Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
Sutapa Mahata, Alok C. Bharti, Shirish Shukla, Abhishek Tyagi, Syed A. Husain and Bhudev C. Das Abstract (provisional) Background Specific types of high risk Human papillomaviruses (HR-HPVs) particularly, HPV types 16 and 18 cause cervical cancer and while the two recently developed vaccines against these HPV types are prophylactic in nature, therapeutic options for treatment […]
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.
Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF. Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA. jamelnikow@ucdavis.edu Abstract OBJECTIVE: To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN). […]
